
AXSM
Healthcare · Biotechnology · $7.45B market cap
$141.69-2.68 (-1.9%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -183.6% over 90 days · 30-day revisions 4 up, 4 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 2, 2026 | Before the open | -0.69 | -0.25 | +63.8% |
| Aug 10, 2026 | Before the open | -0.99 | -0.99 | 0.0% |
| May 4, 2026 | Before the open | -0.86 | -1.26 | -46.5% |
| Feb 23, 2026 | Time not confirmed | -0.73 | -0.56 | +22.8% |
| Nov 3, 2025 | Before the open | -0.90 | -0.94 | -4.4% |
| Aug 4, 2025 | Before the open | -1.09 | -0.97 | +11.0% |
| May 5, 2025 | Before the open | -1.35 | -1.22 | +9.6% |
| Feb 18, 2025 | Before the open | -1.00 | -1.54 | -53.6% |
| Nov 12, 2024 | Before the open | -1.41 | -1.34 | +4.8% |
| Aug 5, 2024 | Before the open | -1.33 | -1.67 | -25.6% |
| May 6, 2024 | Before the open | -1.22 | -1.44 | -18.0% |
| Feb 20, 2024 | Before the open | -1.17 | -2.08 | -77.8% |
| Nov 6, 2023 | Before the open | -1.19 |
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major…
| -1.32 |
| -10.9% |
| Aug 7, 2023 | Before the open | -1.20 | -1.54 | -28.3% |
| May 8, 2023 | Before the open | -1.04 | -0.26 | +75.0% |
| Feb 27, 2023 | Before the open | -1.14 | -1.41 | -23.7% |
| Nov 7, 2022 | Before the open | -1.10 | -1.07 | +2.7% |
| Aug 9, 2022 | Before the open | -1.12 | -1.06 | +5.4% |
| May 2, 2022 | Before the open | -1.01 | -1.03 | -2.0% |
| Mar 1, 2022 | Before the open | -1.02 | -0.90 | +11.8% |
| Nov 8, 2021 | Before the open | -0.93 | -0.93 | 0.0% |
| Aug 9, 2021 | Before the open | -0.88 | -0.86 | +2.3% |
| May 10, 2021 | After the close | -0.81 | -0.78 | +3.7% |
| Mar 1, 2021 | Before the open | -0.76 | -0.78 | -2.6% |
| Nov 5, 2020 | After the close | -0.55 | -0.58 | -5.5% |
| Aug 10, 2020 | Before the open | -0.61 | -0.49 | +19.7% |
| May 8, 2020 | Before the open | -0.62 | -0.88 | -41.9% |
| Mar 12, 2020 | Before the open | -0.46 | -0.71 | -54.3% |
| Nov 7, 2019 | Before the open | -0.39 | -0.56 | -43.6% |
| Aug 8, 2019 | Before the open | -0.31 | -0.41 | -32.3% |
| May 9, 2019 | Before the open | -0.30 | -0.32 | -6.7% |
| Mar 14, 2019 | Before the open | -0.30 | -0.32 | -6.7% |
| Nov 9, 2018 | Before the open | -0.28 | -0.31 | -10.7% |
| Aug 8, 2018 | Before the open | -0.27 | -0.32 | -18.5% |
| May 8, 2018 | Before the open | -0.28 | -0.29 | -3.6% |
| Mar 7, 2018 | Before the open | -0.31 | -0.31 | 0.0% |